首页> 美国卫生研究院文献>Frontiers in Physiology >The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis
【2h】

The Clinicopathological and Prognostic Implications of FoxP3+ Regulatory T Cells in Patients with Colorectal Cancer: A Meta-Analysis

机译:大肠癌患者FoxP3 +调节性T细胞的临床病理和预后意义:荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background and Objective: Forkhead box P3 (FoxP3) is known as the specific marker for regulatory T lymphocytes (Tregs), which are responsible for self-tolerance and disturb the antitumor immunity. However, the prognostic implication of tumor-infiltrating FoxP3+ Tregs in patients with colorectal cancer (CRC) still remains controversial. The aim of this present study was to investigate the prognostic role of FoxP3+ Tregs in CRC through meta-analysis.>Methods: PubMed, Embase and Web of Science were searched for relevant articles up to December 12, 2016. Pooled hazard ratio (HR) and 95% confidence interval (CI) were calculated to explore the prognostic value of FoxP3+ Tregs in CRC. Odds ratio (OR) was calculated to investigate the correlation between FoxP3+ Tregs and pathological parameters.>Results: A total of 18 studies comprising 3,627 patients with CRC were enrolled in our meta-analysis. The combined HR for FoxP3+ Tregs on cancer-specific survival was 0.70 (95% CI = 0.62–0.80, P < 0.001). High FoxP3+ Tregs level was also associated with favorable prognosis on overall survival (HR = 0.76, 95% CI = 0.58–1.01, P = 0.058), with P-value very close to the statistical threshold. Yet, there was no correlation between FoxP3+ Tregs infiltration and disease-free survival (HR = 0.83, 95% CI = 0.63–1.09, P = 0.182). Moreover, FoxP3+ Tregs infiltration was significantly correlated with pT stage (OR = 0.50, 95% CI = 0.39–0.65, P < 0.001), tumor grade (OR = 0.77, 95% CI = 0.61–0.98, P = 0.032), lymphatic invasion (OR = 0.25, 95% CI = 0.07–0.89, P = 0.033) and vascular invasion (OR = 0.67, 95% CI = 0.52–0.86, P = 0.001).>Conclusion: The present meta-analysis suggests that high FoxP3+ Tregs infiltration is inclined to indicate favorable prognosis and is associated with the pathogenesis of CRC. Immunotherapy targeting Tregs in patients with CRC should be further investigated.
机译:>背景和目的:叉头盒P3(FoxP3)被称为调节性T淋巴细胞(Tregs)的特异性标志物,负责自我耐受并干扰抗肿瘤免疫力。然而,肿瘤浸润的FoxP3 + Tregs在大肠癌(CRC)患者中的预后意义仍然存在争议。本研究的目的是通过荟萃分析研究FoxP3 + Treg在CRC中的预后作用。>方法:搜索PubMed,Embase和Web of Science文章截至2016年12月12日。计算合并危险比(HR)和95%置信区间(CI),以探讨FoxP3 + Treg在CRC中的预后价值。计算比值比(OR)以研究FoxP3 + Treg与病理参数之间的相关性。>结果:总共有18项研究(包括3,627例CRC患者)纳入了我们的meta -分析。 FoxP3 + Treg对癌症特异性存活的合并HR为0.70(95%CI = 0.62-0.80,P <0.001)。 FoxP3 + 高Tregs水平也与总体生存预后良好相关(HR = 0.76,95%CI = 0.58–1.01,P = 0.058),P值非常接近统计阈值。然而,FoxP3 + Treg的浸润与无病生存率之间没有相关性(HR = 0.83,95%CI = 0.63–1.09,P = 0.182)。此外,FoxP3 + Treg的浸润与pT分期(OR = 0.50,95%CI = 0.39–0.65,P <0.001),肿瘤等级(OR = 0.77,95%CI = 0.61– 0.98,P = 0.032),淋巴管浸润(OR = 0.25,95%CI = 0.07–0.89,P = 0.033)和血管浸润(OR = 0.67,95%CI = 0.52-0.86,P = 0.001)。>结论:目前的荟萃分析表明,FoxP3 + Tregs高浸润倾向于预后良好,并与CRC的发病有关。针对CRC患者中针对Treg的免疫疗法应进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号